Gruppe von Forschenden)

CSL Research Acceleration Initiative

CSL Research Acceleration Initiative Marburg and Giessen

CSL and the Universities of Marburg, Giessen and the MPI-HLR wish to establish new collaborative partnerships to accelerate research. Eligible are researchers/clinicians employed by the Universities of Marburg or Giessen or the MPI-HLR working in a Therapeutic Area and a Focus Area and/or Modality listed below. Application closes Sunday, 15th December 2019.

Eligible? Download and submit the application form now!

Apply now
scientist with test tube
Therapeutic Areas



two scientists with microscopes taking notes

Novel drug targets
Clinical sample and/or clinical data collaborations
Novel platforms or technologies relevant to CSL Therapeutic Area or Modality
Novel delivery strategies and enhancements for biologics, gene or cell therapies
Biomarkers of disease
New uses for CSL’s on-market products

young female scientist in a group of young scientists taking notes on a flipboard

Protein therapeutics
Gene therapies
Cell therapies
Small molecules NOT of interest

Why collaborate with CSL?

Collaborate with one of the world’s leading biopharmaceutical companies.
Global capabilities on your doorstep.
Access to commercial R&D, clinical, intellectual property, marketing and manufacturing expertise.

Accelerate translation of your research to deliver new life-saving therapies to patients.

Funding for successful proposals.
two people shaking hands

Download the info flyer or contact Marco Cavallari, Senior Advisor Research Innovation, at for more details.

Weitere Informationen zu Forschung und Entwicklung finden Sie auf der globalen Website von CSL Behring.

Mehr erfahren
Soziale Verantwortung

Wir handeln jederzeit ehrlich und auf ethisch korrekte Weise. Mehr erfahren

Mehr erfahren
Etwas zurückgeben

Die Unterstützung unserer Patientengemeinschaften ist Teil unserer Verantwortung.

Mehr erfahren

Schreiben Sie zusammen mit den talentiertesten, engagiertesten Personen verschiedenster Fachbereiche Geschichte.

Mehr erfahren